News & Press Releases
Filter by:
Mintz Member Daniel Cody shared insights with Law360 Healthcare Authority on the DOJ’s recent affirmation of its support for the False Claims Act’s qui tam provisions. The agency’s position was outlined in a recent court brief filed in the high-profile Eleventh Circuit case challenging the constitutionality of the provisions.
Managing IP featured the one-year anniversary of Life Science Litigation Practice Chair and Patent Litigation Practice Co-chair Sige Gutman and his team joining Mintz, highlighting the growth of the firm’s Life Sciences Litigation Practice. In the article, Sige discusses the group’s strategic approach, emphasizing the importance of cross-disciplinary knowledge and creative problem-solving.
Intellectual Property Division Chair Michael Renaud shared insights with Managing IP on the current landscape of intellectual property monetization. He discusses global IP trends, including increasing licensing activity at the UPC, potential market implications, and his experience advising clients on IP monetization.
Member Reza Dokhanchy, Intellectual Property Division Chair Michael Renaud, and Associate Amy LoBue wrote an article featured in IP Litigator on why the US International Trade Commission is the best venue for standard-essential patent (SEP) holders to assert their patents, despite common misconceptions that SEPs cannot be successfully asserted there.
Mintz has been recognized among the Top 25 Los Angeles Law Firms in Real Estate and Top 125 Los Angeles Law Firms overall by LA Times Studios.
Regulatory Uncertainty Continues as US ESG Rule Under Threat
April 28, 2025
ESG Practice Co-chair Jacob Hupart recently connected with Responsible Investor about the Department of Labor’s decision to reconsider, and potentially rescind, its ‘ESG rule’. The decision comes as the rule faces ongoing court challenges and amid broader regulatory rollbacks under the Trump administration.
